Immuneering Corporation - Class A Common Stock (NQ:IMRX)
1.577
+0.077
(+5.10%)
Streaming Delayed Price
Updated: 11:27 AM EDT, Apr 2, 2025
Add to My Watchlist
All News about Immuneering Corporation - Class A Common Stock![]() ![]() ![]() ![]() Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
The Week Ahead In Biotech: Cara FDA Decision, Ascendis Earnings, Aileron Data Presentation And More
August 22, 2021
Via Benzinga
Exposures
Product Safety
![]() ![]() ![]()
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|